日本医保覆盖机器人辅助手术的现状与十年趋势:基于NDB开放数据的全国索赔研究
该研究利用日本NDB开放数据(2014-2023)分析医保覆盖的机器人辅助手术(RAS)的全国推广与分布。至2023年,47项RAS手术归入4个外科领域的20类,年手术量达95,845例,泌尿外科占比最大(40,673例),其次为胃肠外科和妇科。RAS采用存在明显都道府县差异,且与认证机器人手术导师数量相关。
要点
- 2023年日本医保覆盖RAS手术达47项、20类,年总量95,845例。
- 泌尿外科RAS量最大(40,673例),胃肠外科中食管切除和直肠切除采用率较高。
- RAS采用存在地区差异,部分术式与认证导师数量强相关。
核心结论
- 日本医保覆盖的RAS手术量快速扩张,术式和地区差异显著,人群层面数据可为机器人手术实施策略和卫生政策提供参考。
研究设计与样本
- 基于日本NDB开放数据(2014-2023)的全国性人群索赔研究,纳入截至2023财年所有医保覆盖的RAS手术及对应的内镜和开放手术。
主要发现
- 至2023年,47项医保覆盖机器人手术归入4个外科领域的20类,年RAS量达95,845例。
- 泌尿外科占比最大(40,673例),其次为胃肠外科和妇科;根治性前列腺切除最常见,其次为直肠切除和恶性肿瘤肾切除。
- 泌尿外科机器人利用率最高;胃肠外科中食管切除和直肠切除采用率相对较高。
- 存在明显的都道府县差异,模式因术式而异,且与微创手术率不完全一致。
- 若干术式中RAS采用与认证机器人手术导师数量强相关;胃切除等选定术式中机器人和微创利用率随年龄增长而下降。
临床怎么用
- 关注不同术式和地区的RAS采用差异,结合认证导师配置规划机器人手术推广。
- 对老年患者(如胃切除)需注意机器人和微创利用率随年龄下降的趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since reimbursement under Japan's National Health Insurance system, robot-assisted surgery (RAS) has expanded rapidly. However, comprehensive cross-disciplinary analyses describing long-term adoption trends and regional variation remain limited. This study aimed to evaluate nationwide adoption and distribution of reimbursed RAS across surgical specialties in Japan. METHODS: We performed a population-based study using publicly available claims data from the National Database (NDB) Open Data (2014-2023). All procedures reimbursed as RAS as of fiscal year 2023, along with corresponding endoscopic and open procedures, were included. Ten-year trends in RAS volume were analyzed across surgical fields and procedure categories. For representative procedures in fiscal year 2023, prefecture-level and age- and sex-specific variations in surgical approach were examined. RESULTS: By 2023, 47 reimbursed robotic procedures were classified into 20 categories across four surgical fields. Annual RAS volume increased markedly, reaching 95,845 procedures in 2023. Urology accounted for the largest share (40,673 cases), followed by gastrointestinal surgery and gynecology. Radical prostatectomy was the most common robotic procedure, followed by rectal resection and nephrectomy for malignant tumors. Robotic utilization was highest in urology; within gastrointestinal surgery, esophagectomy and rectal resection showed relatively high adoption. Substantial prefecture-level variation was observed, with patterns differing by procedure and not consistently correlating with minimally invasive surgery rates. RAS adoption was strongly associated with the number of certified robotic surgery proctors in several procedures. For selected procedures, including gastrectomy, robotic and minimally invasive utilization decreased with increasing age. CONCLUSION: RAS has expanded rapidly in Japan, with marked procedural and regional variation. These population-level findings may inform implementation strategies and health policy for robotic surgery.
引用
- Taura K, Fukuda M, Tanaka E, et al. Current status and 10-year trends of reimbursed robot-assisted surgery in Japan: a nationwide claims-based study using the NDB Open Data. Surg Endosc. 2026. PMID: 42806088. doi:10.1007/s00464-026-13374-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。